While the market fixates on short-term product cycles, Hims & Hers (HIMS) is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personaliz
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, announced that it's heading back to the Big Game this year. On Febru

Hims & Hers: It's Time To Get Aggressive

06:15pm, Wednesday, 28'th Jan 2026
Hims & Hers is a Strong Buy, as shares appear historically cheap due to temporary margin compression and regulatory concerns. HIMS's recurring revenue model, 70%+ gross margins, and rapid subscriber g
Hims & Hers Health, Inc. (HIMS) reached $29.68 at the closing of the latest trading day, reflecting a -1.98% change compared to its last close.
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hims & Hers Health Inc  (NYSE:HIMS) shares are up 3.4% to trade at $30.60 at last glance.
HIMS expands its tech-driven care platform with new diagnostics, AI tools and specialty treatments for personalized health.
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both mid-cap medical companies, but which is the better investment? We will contrast th

Hims & Hers Health: The Reset Nobody Expected

05:00am, Sunday, 25'th Jan 2026
Revenue grew nearly 50% year over year in Q3 2025 to ~$600 million, with ARPU rising and free cash flow reaching $79 million. Gross margin declined to ~74% from high-70s levels due to GLP-1 shipping c
Stock News TikTok sets up U.S. data-security JV: TikTok USDS Joint Venture LLC launched as a majority American-owned entity to safeguard U.S. user data, algorit
Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right now? Let's dive in.
Emerald Advisers LLC acquired a new position in shares of Hims and Hers Health, Inc. (NYSE: HIMS) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Com
Hims and Hers Health (NYSE: HIMS - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses

2 Top Stocks to Double Up On Right Now

07:05pm, Tuesday, 20'th Jan 2026
Amazon could be on the cusp of an artificial intelligence (AI)-driven boom in profitability. Hims & Hers Health stock is pricey, but the company's massive growth potential makes up for it.
HIMS leverages a software-driven platform to scale personalized digital care across new health categories and markets.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE